Source:http://linkedlifedata.com/resource/pubmed/id/12199804
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2002-8-29
|
pubmed:databankReference | |
pubmed:abstractText |
Hereditary hyperferritinaemia-cataract syndrome (HHCS) (OMIM #600886) is a rare autosomal dominant condition identified by high serum ferritin levels with normal iron saturation and distinctive bilateral cataract. It may be misdiagnosed as haemochromatosis and such patients become anaemic as a result of inappropriate venesection. The elevated serum ferritin is due to a mutation in the iron-responsive element (IRE) of the l-ferritin gene, resulting in excessive l-ferritin production. We report the identification of three Australian pedigrees; one with a previously described mutation at position 40, a pedigree with a novel mutation at position 39 and an individual with a de novo mutation at position 32 of the l-ferritin IRE.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1179-82
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12199804-Adult,
pubmed-meshheading:12199804-Australia,
pubmed-meshheading:12199804-Cataract,
pubmed-meshheading:12199804-Child,
pubmed-meshheading:12199804-DNA Mutational Analysis,
pubmed-meshheading:12199804-Female,
pubmed-meshheading:12199804-Ferritins,
pubmed-meshheading:12199804-Humans,
pubmed-meshheading:12199804-Iron-Regulatory Proteins,
pubmed-meshheading:12199804-Male,
pubmed-meshheading:12199804-Middle Aged,
pubmed-meshheading:12199804-Pedigree,
pubmed-meshheading:12199804-Syndrome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Mutation spectrum in Australian pedigrees with hereditary hyperferritinaemia-cataract syndrome reveals novel and de novo mutations.
|
pubmed:affiliation |
Douglas Hocking Research Institute, Geelong, Australia. janetmc@barwonhealth.org.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|